Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study

A Correction to this paper has been published: https://doi.org/10.1007/s00125-021-05460-0

Saved in:
Bibliographic Details
Published inDiabetologia Vol. 64; no. 8; pp. 1900 - 1901
Main Authors Ji, Linong, Du, Ying, Xu, Min, Zhou, Xiangjun, Mo, Zhaohui, Ma, Jianhua, Li, Jiarui, Li, Yufeng, Lin, Jingna, Wang, Yanjun, Yang, Jing, Song, Weihong, Jin, Hui, Pang, Shuguang, Liu, Hui, Li, Ping, Liu, Jie, Yao, Minxiu, Li, Wenhui, Jiang, Xiaohong, Shen, Feixia, Geng, Houfa, Zhou, Haifeng, Ran, Jianmin, Lei, Minxiang, Du, Yinghong, Ye, Shandong, Guan, Qingbo, Lv, Wenshan, Tan, Huiwen, Chen, Tao, Yang, Jinkui, Qin, Guijun, Li, Shiyun, Chen, Lei
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2021
Springer Nature B.V
Subjects
Correction
Human Physiology
Internal Medicine
Medicine
Medicine & Public Health
Metabolic Diseases
Online AccessGet full text

Cover

More Information
Summary:A Correction to this paper has been published: https://doi.org/10.1007/s00125-021-05460-0
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:0012-186X
1432-0428
DOI:10.1007/s00125-021-05460-0